In: Non-small cell lung cancer

Plinabulin

BeyondSpring · NPI-2358 · BPI-2358

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
5 in total
Targets
 

What this is

How it works
Tubulin-binding agent
How it’s given
“Plinabulin will be administered by IV infusion at 30 mg/m² over approximately 1 hour on Days 1 and 8 of each 21-day treatment cycle. On Day 1, plinabulin will be administered approximately 1 hour after completion of the docetaxel infusion.”In the company’s words, NCT07361484 on ClinicalTrials.gov
Tested for
Non-Small Cell Lung Cancer, Non-squamous Non-Small Cell Lung Cance
Main trialPhase 3
“This is a global, multicenter, randomized, double-blind, placebo-controlled Phase 3 study evaluating docetaxel plus plinabulin versus docetaxel plus placebo in participants with advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) without EGFR, ALK, ROS1, or RET alterations who have experienced disease progression after prior anti-PD-1/PD-L1 immunotherapy and platinum-based chemotherapy. Approximately 442 participants will be randomized 1:1 to receive docetaxel (75 mg/m² IV on Day 1 of each 21-day cycle) in combination with plinabulin (30 mg/m² IV on Days 1 and 8) or…”In the company’s words, NCT07361484 on ClinicalTrials.gov
Other names
NPI-2358 · BPI-2358

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 3Not yet recruiting 1 Jun 2029 Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)
Phase 3Completed 12 Dec 2018 Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
Phase 3Unknown 25 Sep 2020 Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia
Phase 3Completed 21 Jul 2021 Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC
Phase 2Completed 20 Mar 2018 Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 16 Nov 2026 · EU trials register (CTIS) updated 16 Nov 2026 · openFDA updated 13 Nov 2026

Follow Plinabulin

Following is part of Solo: you see every change to Plinabulin the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in